Eli Lilly Stock Hits a New All-Time High: Has It Gotten Too Expensive to Buy?
Shares of Eli Lilly have risen by over 40% since the company last reported earnings.
Overview
Eli Lilly (NYSE: LLY) stock has been rallying in recent months, taking off from around $850 in late April to more than $1,200 as of Monday's close, for an increase of more than 40% over that stretch. It's a massive rally for the stock in such a short time frame, which has recently pushed it up to not only a new 52-week high but also a new all-time high.
The healthcare giant's market cap has climbed back above the $1 trillion mark in the process. But the big question for investors is whether it's gotten too hot to buy; can Eli Lilly stock still be a good buy at around $1,200?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.